More than 25 years of successful early phase drug development experience delivering pivotal registration studies Holds a Neuro & Molecular Pharmacology Master’s degree Scientific expertise includes design and delivery of cell therapies, targeted small molecules, immune-oncology clinical development plans across rare indications, solid tumor, and hematological malignancies Experience leading global teams and all phases of oncology clinical development programs for both large and mid-size pharmaceutical and biotechnology clients
